Clinical trial

VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent…

NCT00317239 · American Regent, Inc., Industry · Completed

Key facts

NCT number NCT00317239
Title VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
Official title Comparison of Safety & Efficacy of a Unique Intravenous Iron (VIT45) Preparation vs Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
Lead sponsor American Regent, Inc., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Anemia
Intervention type Drug
Interventions Ferrous Sulfate tablets, Ferric Carboxymaltose (FCM)
Enrollment 255
Start date May 1, 2005
Primary completion Feb 1, 2007
Completion Aug 1, 2007
First posted Apr 24, 2006
Last update posted Feb 20, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies